TG Therapeutics Highlights Schedule of Data Presentations for BRIUMVI (ublituximab) in Multiple Sclerosis at the ANN 2024 Annual Meeting

Press/Media

Period20 Mar 2024

Media coverage

1

Media coverage

  • TitleTG Therapeutics Highlights Schedule of Data Presentations for BRIUMVI (ublituximab) in Multiple Sclerosis at the ANN 2024 Annual Meeting
    Media name/outletEntertainment Close-Up (Close-up Media)
    Country/TerritoryUnited States
    Date20/03/24
    PersonsStephen C. Krieger
View all 1
View less